These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 10868502)
1. Olanzapine: extrapyramidal side effects in the elderly. Granger AS; Hanger HC Aust N Z J Med; 1999 Jun; 29(3):371-2. PubMed ID: 10868502 [No Abstract] [Full Text] [Related]
2. Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine. Rudolf J; Ghaemi M; Schmülling S Eur Psychiatry; 1999 Oct; 14(6):356-7. PubMed ID: 10572371 [TBL] [Abstract][Full Text] [Related]
3. Olanzapine can worsen parkinsonism. Jiménez-Jiménez FJ; Tallón-Barranco A; Ortí-Pareja M; Zurdo M; Porta J; Molina JA Neurology; 1998 Apr; 50(4):1183-4. PubMed ID: 9566425 [No Abstract] [Full Text] [Related]
4. Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note. Graham JM; Sussman JD; Ford KS; Sagar HJ J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):774-7. PubMed ID: 9810956 [TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia from risperidone and olanzapine in an alcoholic man. Snoddgrass PL; Labbate LA Can J Psychiatry; 1999 Nov; 44(9):921. PubMed ID: 10584163 [No Abstract] [Full Text] [Related]
6. Olanzapine usage associated with neuroleptic malignant syndrome. Philibert RA; Adam LA; Frank FM; Carney-Doebbeling C Psychosomatics; 2001; 42(6):528-9. PubMed ID: 11815691 [No Abstract] [Full Text] [Related]
9. Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine. Onofrj M; Thomas A; Bonanni L; Iacono D; Gambi F Neurol Sci; 2000 Aug; 21(4):209-15. PubMed ID: 11214659 [TBL] [Abstract][Full Text] [Related]
11. Diabetic ketoacidosis associated with olanzapine in an adolescent patient. Selva KA; Scott SM J Pediatr; 2001 Jun; 138(6):936-8. PubMed ID: 11391346 [TBL] [Abstract][Full Text] [Related]
12. Comment: risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Lu ML; Shen WW Ann Pharmacother; 2002; 36(7-8):1292; author reply 1292-3. PubMed ID: 12086567 [No Abstract] [Full Text] [Related]
13. Speech disturbance and marked decrease in function seen in several older patients on olanzapine. Gaile S; Noviasky JA J Am Geriatr Soc; 1998 Oct; 46(10):1330-1. PubMed ID: 9777929 [No Abstract] [Full Text] [Related]
14. Olanzapine. Hale AS Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205 [TBL] [Abstract][Full Text] [Related]